Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China
· Delayed Price · Currency is CNY 29.43
-0.09 (-0.30%)
Mar 9, 2026, 4:00 PM EDT
SHE:301263 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 490.89 | 541.96 | 455.64 | 806.79 | 137.63 | 93.5 | Upgrade
|
| Trading Asset Securities | 130.34 | 122.1 | 251.8 | 240.65 | - | - | Upgrade
|
| Cash & Short-Term Investments | 621.23 | 664.06 | 707.45 | 1,047 | 137.63 | 93.5 | Upgrade
|
| Cash Growth | 5.40% | -6.13% | -32.46% | 661.05% | 47.19% | 16.95% | Upgrade
|
| Accounts Receivable | 407.44 | 337.06 | 353.04 | 378.49 | 315.95 | 256.4 | Upgrade
|
| Other Receivables | 3.83 | 2.92 | 4.09 | 4.1 | 1.91 | 3.67 | Upgrade
|
| Receivables | 411.27 | 339.98 | 357.14 | 382.59 | 317.86 | 260.07 | Upgrade
|
| Inventory | 131.18 | 105.07 | 86.55 | 80.52 | 76.57 | 99.82 | Upgrade
|
| Other Current Assets | 36.11 | 33.08 | 36.16 | 22.53 | 11.01 | 20.23 | Upgrade
|
| Total Current Assets | 1,200 | 1,142 | 1,187 | 1,533 | 543.07 | 473.63 | Upgrade
|
| Property, Plant & Equipment | 497.04 | 521.27 | 483.74 | 314.54 | 260.24 | 212.23 | Upgrade
|
| Long-Term Investments | 32.45 | 32.45 | 32.45 | 32.45 | - | - | Upgrade
|
| Goodwill | 216.66 | 216.66 | 200.64 | 27.33 | 27.33 | 27.33 | Upgrade
|
| Other Intangible Assets | 189.3 | 159.25 | 158.19 | 66.01 | 44.46 | 47.39 | Upgrade
|
| Long-Term Deferred Tax Assets | 74.5 | 57.09 | 32.64 | 34.19 | 29.31 | 24.87 | Upgrade
|
| Long-Term Deferred Charges | 189.62 | 174.87 | 119.98 | 26.25 | 26.5 | 15 | Upgrade
|
| Other Long-Term Assets | 6.85 | 7.28 | 14.18 | 5.74 | 10.62 | 33.05 | Upgrade
|
| Total Assets | 2,406 | 2,311 | 2,229 | 2,040 | 941.52 | 833.49 | Upgrade
|
| Accounts Payable | 135.3 | 168.37 | 121.19 | 56.59 | 46.92 | 32.38 | Upgrade
|
| Accrued Expenses | 10 | 19.53 | 18.7 | 27.64 | 19.68 | 15.37 | Upgrade
|
| Short-Term Debt | 304.09 | 132.14 | 53.84 | 20.02 | 107.57 | 126.42 | Upgrade
|
| Current Portion of Long-Term Debt | 24.87 | 24.09 | 12.08 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 1.58 | 1.23 | 1.17 | 0.96 | - | Upgrade
|
| Current Income Taxes Payable | 20.91 | 21.78 | 37.02 | 41.54 | 16.55 | 14.28 | Upgrade
|
| Current Unearned Revenue | 3.16 | 3.21 | 4.19 | 5.18 | 9.04 | 18.88 | Upgrade
|
| Other Current Liabilities | 6.93 | 4.26 | 4.89 | 4.17 | 3.76 | 8.05 | Upgrade
|
| Total Current Liabilities | 505.26 | 374.95 | 253.13 | 156.33 | 204.48 | 215.38 | Upgrade
|
| Long-Term Debt | 60 | 84 | 108 | - | - | - | Upgrade
|
| Long-Term Leases | 0.82 | 0.85 | 1.12 | 1.96 | 0.37 | - | Upgrade
|
| Long-Term Unearned Revenue | 13.96 | 15.65 | 16.19 | 19.66 | 19.08 | 19.66 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 17.62 | 19.21 | 21.28 | 7.68 | 7.79 | 8.81 | Upgrade
|
| Total Liabilities | 597.66 | 494.67 | 399.72 | 185.63 | 231.71 | 243.86 | Upgrade
|
| Common Stock | 425.5 | 425.5 | 425.5 | 236.39 | 177.29 | 177.29 | Upgrade
|
| Additional Paid-In Capital | 917.37 | 896.7 | 900.77 | 1,109 | 116.16 | 116.16 | Upgrade
|
| Retained Earnings | 430.91 | 484.08 | 502.91 | 508.18 | 416.3 | 296.24 | Upgrade
|
| Treasury Stock | -39 | -39 | -39 | - | - | - | Upgrade
|
| Comprehensive Income & Other | -0.6 | -0.22 | -0.19 | 0.41 | 0.21 | 0.03 | Upgrade
|
| Total Common Equity | 1,734 | 1,767 | 1,790 | 1,854 | 709.96 | 589.72 | Upgrade
|
| Minority Interest | 74.37 | 49.33 | 39.41 | -0.16 | -0.15 | -0.09 | Upgrade
|
| Shareholders' Equity | 1,809 | 1,816 | 1,829 | 1,854 | 709.81 | 589.63 | Upgrade
|
| Total Liabilities & Equity | 2,406 | 2,311 | 2,229 | 2,040 | 941.52 | 833.49 | Upgrade
|
| Total Debt | 389.78 | 242.65 | 176.27 | 23.16 | 108.9 | 126.42 | Upgrade
|
| Net Cash (Debt) | 231.45 | 421.41 | 531.18 | 1,024 | 28.73 | -32.92 | Upgrade
|
| Net Cash Growth | -30.17% | -20.67% | -48.14% | 3465.41% | - | - | Upgrade
|
| Net Cash Per Share | 0.54 | 1.01 | 1.26 | 2.58 | 0.09 | -0.11 | Upgrade
|
| Filing Date Shares Outstanding | 423.51 | 423.51 | 423.51 | 425.5 | 425.5 | 319.12 | Upgrade
|
| Total Common Shares Outstanding | 423.51 | 423.51 | 423.51 | 425.5 | 319.12 | 319.12 | Upgrade
|
| Working Capital | 694.53 | 767.24 | 934.16 | 1,377 | 338.59 | 258.24 | Upgrade
|
| Book Value Per Share | 4.09 | 4.17 | 4.23 | 4.36 | 2.22 | 1.85 | Upgrade
|
| Tangible Book Value | 1,328 | 1,391 | 1,431 | 1,761 | 638.18 | 515 | Upgrade
|
| Tangible Book Value Per Share | 3.14 | 3.28 | 3.38 | 4.14 | 2.00 | 1.61 | Upgrade
|
| Buildings | - | 448.01 | 208.1 | 205.74 | 207.64 | 164.45 | Upgrade
|
| Machinery | - | 284.45 | 203.9 | 187.35 | 171.81 | 151.26 | Upgrade
|
| Construction In Progress | - | 2.44 | 247.02 | 66.37 | 2.01 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.